Activation_NN
of_IN
human_JJ
thymocytes_NNS
after_IN
infection_NN
by_IN
EBV_NN
._.

The_DT
discovery_NN
of_IN
EBV_NN
in_IN
certain_JJ
T_NN
cell_NN
malignancies_NNS
and_CC
the_DT
expression_NN
of_IN
the_DT
EBV_NN
receptor_NN
,_,
CR2\/CD21_NN
,_,
on_IN
a_DT
population_NN
of_IN
immature_JJ
thymocytes_NNS
,_,
T_NN
lymphoblastoid_JJ
cell_NN
lines_NNS
,_,
and_CC
childhood_NN
acute_JJ
T_NN
lymphoblastic_JJ
leukemia_NN
cells_NNS
suggested_VBD
that_IN
EBV-receptor_NN
interactions_NNS
on_IN
T_NN
cells_NNS
may_MD
be_VB
of_IN
importance_NN
._.

We_PRP
have_VBP
shown_VBN
that_IN
,_,
within_IN
the_DT
thymus_NN
,_,
a_DT
population_NN
of_IN
large_JJ
,_,
immature_JJ
cells_NNS
expresses_VBZ
CD21_NN
._.

EBV_NN
altered_VBD
the_DT
activation_NN
responses_NNS
of_IN
immature_JJ
thymocytes_NNS
in_FW
vitro_FW
._.

Triggering_NN
through_IN
CD2_NN
is_VBZ
mitogenic_JJ
for_IN
mature_JJ
,_,
but_CC
not_RB
immature_JJ
,_,
T_NN
cells_NNS
._.

However_RB
,_,
during_IN
infection_NN
by_IN
EBV_NN
,_,
ligation_NN
of_IN
CD2_NN
caused_VBD
thymocytes_NNS
to_TO
proliferate_VB
in_IN
the_DT
absence_NN
of_IN
exogenous_JJ
cytokines_NNS
._.

This_DT
function_NN
was_VBD
a_DT
result_NN
of_IN
the_DT
interaction_NN
of_IN
EBV_NN
with_IN
its_PRP$
receptor_NN
,_,
CD21_NN
,_,
but_CC
was_VBD
caused_VBN
by_IN
infection_NN
rather_RB
than_IN
surface_NN
signaling_NN
,_,
because_IN
neither_CC
specific_JJ
mAb_NN
nor_CC
the_DT
P3HR-1_NN
strain_NN
of_IN
virus_NN
mimicked_VBD
the_DT
effect_NN
of_IN
B95-8_NN
._.

Immature_JJ
thymocytes_NNS
were_VBD
infected_VBN
by_IN
EBV_NN
,_,
as_IN
determined_VBN
by_IN
the_DT
internalization_NN
of_IN
the_DT
viral_JJ
genome_NN
and_CC
its_PRP$
transcriptional_JJ
activity_NN
._.

Consistent_JJ
with_IN
the_DT
activity_NN
of_IN
B95-8_NN
,_,
EBNA-2_NN
transcripts_NNS
were_VBD
identified_VBN
within_IN
infected_JJ
thymocyte_NN
populations_NNS
._.

In_IN
addition_NN
,_,
components_NNS
of_IN
the_DT
viral_JJ
replicative_JJ
pathway_NN
were_VBD
expressed_VBN
during_IN
infection_NN
of_IN
thymocytes_NNS
._.

These_DT
components_NNS
included_VBD
transcription_NN
of_IN
BZLF-1_NN
,_,
an_DT
early_JJ
gene_NN
that_WDT
characterizes_VBZ
EBV-infected_JJ
B_NN
cells_NNS
after_IN
disruption_NN
of_IN
latency_NN
._.

A_DT
second_JJ
transcript_NN
was_VBD
identified_VBN
as_IN
encoding_VBG
the_DT
recently_RB
characterized_VBN
RAZ_NN
,_,
which_WDT
also_RB
is_VBZ
associated_VBN
with_IN
replicative_JJ
infection_NN
._.

The_DT
consequences_NNS
of_IN
EBV_NN
infection_NN
of_IN
T_NN
cells_NNS
at_IN
an_DT
early_JJ
stage_NN
of_IN
differentiation_NN
may_MD
lead_VB
to_TO
failure_NN
of_IN
normal_JJ
T_NN
cell_NN
repertoire_NN
development_NN
,_,
autoimmunity_NN
,_,
or_CC
malignancy_NN
._.

